15
Nutrition Management Guidelines Nutrition Guideline Development Process Very Long Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)

Nutrition Guideline Development Process

  • Upload
    others

  • View
    13

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Nutrition Guideline Development Process

Nutrition Management Guidelines

Nutrition Guideline Development Process

Very Long Chain Acyl-CoA Dehydrogenase Deficiency

(VLCAD)

Page 2: Nutrition Guideline Development Process

Nutrition Management Guidelines

The mission of GMDI is to provide standards of excellence and leadership in nutrition therapy for genetic metabolic disorders through clinical practice, education, advocacy, and research.

Page 3: Nutrition Guideline Development Process

Nutrition Management Guidelines Project Organization

HRSA

SoutheastRegionalGeneticsNetwork(SERN)

NationalAdvisoryBoard

SERNProjectStaffAdryaStembridge,YetsaOsara,

KatieCoakleyProjectStaffandFunding

GeneticMetabolicDietitiansInternational(GMDI)

-ContentExpertise

RaniH.Singh,PI FranRohr,Co-PI

PatSplettDianneFrazier

Consultants

AdryaStembridge

ITandPortal

Librarian

Chair:DianneFrazier

AminoAcidopathies

MSUD

Chairs:AmyCunninghamShidehMofidi

PKU

Chairs:SandyVanCalcar

MarySowa

FattyAcidOxidationDisorders

CoreGroup

Workgroups

Chair: Rani Singh

Urea Cycle Disorders

(future)

Chairs:KeikoUedaElainaJurecki

OrganicAcidopathies

PROP

Page 4: Nutrition Guideline Development Process

Nutrition Management Guidelines

Nutrition Guideline Development Process

Evidence/ConsensusAnalysis• SystematicReviewofpublishedliteratureand“grayliterature”

DelphiProcess–Round1• Surveyofexpertpractioners–MDsandRDsHRSAGeneticsRegions

WorkgroupEvidenceSummaryandPreliminaryRecommendations• Recommendationsfornutritionmanagementbasedonliteraturereview• IdentificationofvariationsinpracticebasedonDelphisurvey

NominalGroupTechnique• Face-to-Facemeetingofexpertpanel• Discussareasofpracticevariation,vote,discussrecommendations,voteagain

DelphiProcess-Round2• SurveyofrecommendationsandvariationsinpracticeidentifiedbyNominalGroupTechniquepanel

ReviewProcess• ExternalReviewandFieldTesting

WritingNutritionGuidelines-Workgroups• Recommendationsfornutritionmanagement• Documentationofareasofconsensusandnon-consensus

Page 5: Nutrition Guideline Development Process

Nutrition Management Guidelines VLCADGuidelinesWorkgroup

•  PeopleInvolved– CoreGroup:10– QualityCriteriaAnalysts:10– WorkgroupEvidenceAnalysts:16– DelphiSurveyRespondents:17– NominalGroupExperts:9

Page 6: Nutrition Guideline Development Process

Nutrition Management Guidelines

VLCADbytheNumbers•  ResearchQuestions6•  Literaturesearcharticles:951•  Formalliteratureincluded:93•  Grayliteratureincluded:26•  Formalliteratureexcluded:858

–  Animalorin-vitrostudy–  NotpublishedinEnglishlanguage–  UnrelatedtoVLCADtreatmentoroutcomes–  Geneticstudiesnotrelatedtophenotype–  Generaloverviewarticleintendedtoeducatethose

notfamiliarwithVLCAD–  Publishedpriorto1990

Page 7: Nutrition Guideline Development Process

Nutrition Management Guidelines Guideline Template

•  Background –  Definition –  Incidence –  Pre-symptomatic detection –  Genetics –  Confirmatory testing

•  Biochemical Basis –  Rationale for treatment –  Biochemical pathway

•  Nutrition Assessment –  Signs and Symptoms –  Laboratory Findings

•  Nutrition Problem Identification –  Common Diagnoses using NCP language

•  Nutrition Management –  Healthy –  Ilnesss –  Supplements –  Exercise –  Pregnancy

•  Education –  Patient Goals –  Patient Resource –  Provider Resources

•  Monitoring and Evaluation –  Biomarkers to follow –  Health benefits –  Harms (side effects, risks)

•  Barriers to Implementation •  References

Page 8: Nutrition Guideline Development Process

Nutrition Management Guidelines ExpectedProducts

•  Guidelines–  Evidenceandconsensusbasedrecommendationsfornutritionmanagement

•  Toolkit–  Casestudy-basedpracticalapproachwithresources

•  FAQSheet/GuidelineSummary–  Forparents

•  Publication–  Peer-reviewedjournal

Page 9: Nutrition Guideline Development Process

Nutrition Management Guidelines

F i r s t Ed i t i o n 2 0 1 8 S E R N / G M D I N u t r i t i o n M a n a g e m e n t G u i d e l i n e s NUTRIENT INTAKE

How much protein can I consume?

The amount depends on individual1,2 tolerance, age, weight, and growth (children) or health maintenance (adults). Your dietitian will use your lab results and your clinical status to adjust your protein goals. (Rec 1.12)

Do I need a PROP3 formula? PROP formula is needed if your food protein tolerance is less than the amount of protein recommended for your age. (Rec 1.22)

How do I know if I am getting the right number of calories?

The correct number of calories is based on age, weight, activity level and growth (children) or health maintenance (adults). Your dietitian will recommend the right amount of calories for you. Most individuals with PROP need extra calories when ill. (Rec 1.5,2.12)

SUPPLEMENTS Do I need isoleucine or valine supplements?

If your blood levels of isoleucine or valine are too low, your dietitian may increase food (intact) protein and PROP medical formula protein to bring isoleucine or valine blood levels up rather than giving amino acid supplements. (Rec 1.1,1.32)

Do I need carnitine? Most individuals with PROP need to take a carnitine supplement to keep their blood carnitine level within the normal range. (Rec 3.12)

Should I take prebiotics? More research is needed. Discuss with your physician and dietitian if prebiotics (non-digestible substances in foods, usually fiber) are right for you to support bowel health. (Rec 3.62)

BLOOD MONITORING What are the goals for isoleucine, valine, threonine and methionine blood levels?

For individuals with PROP the goal is to maintain amino acid levels in the blood within the normal range. (Rec 1.1, 1.3, 4.42)

How often should blood testing be done?

Your physician and dietitian will work with you to establish a lab testing schedule that is best for you based on past lab results. Discuss with your team how often to come to clinic to check your labs as well as your health and nutrition status. (Rec 4.4, 4.52)

ILLNESS What should I do if I become ill? Call your metabolic physician. Refer to your emergency letter. (Rec 2.72) How does management change during illness?

Sick day instructions from your metabolic physician and dietitian may include: Reduce or hold protein intake, but for no more than 48 hours Increase liquids and calories Stay in contact with your metabolic clinic to report any changes For more severe illnesses, medications such as Carbaglu® or Flagyl® may be recommended. (Rec 2.7, 3.3, 3.42)

LIVER TRANSPLANT How does treatment for PROP change after a liver transplant?

After transplant, an individual with PROP may be able to increase food (intact) protein intake to the recommended amount for someone their age without PROP. Most will likely need to continue taking carnitine and stay in contact with their metabolic clinic. (Rec 7.4, 7.52)

PREGNANCY Have any women with PROP been able to have children?

With close monitoring and medical management women with PROP have had children. (Rec 5.2, 5.3, 5.4, 5.52)

This document is not meant to substitute for the medical advice provided by your doctor.

1. For the child, teenager, or adult living with PROP and their caregivers. 2. Based on the 2017 Nutrition Management Guidelines for Propionic Acidemia (PROP) by Genetic Metabolic Dieticians International (GMDI)/ Southeast Regional Genetics Network (SERN): https://southeastgenetics.org/ngp/guidelines_prop.php 3. The Management Guidelines Advisory Committee used the nationally standardized condition abbreviation of PROP; curated by the US National Library of Medicine for this and related guideline products: https://newbornscreeningcodes.nlm.nih.gov/

SOUTHEAST REGIONAL GENETICS NETWORK — A HRSA SUPPORTED PARTNERSHIP — GRANT #UH7MC30772

Page 10: Nutrition Guideline Development Process

Nutrition Management Guidelines MildVLCAD

•  Infantshavemildlytomoderatelyelevatedconcentrationsoflongchainacylcarnitinesonnewbornscreening.

•  Diagnostictestingshouldconfirmthediagnosis,althoughtheplasmaacylcarnitineprofilemaybenearnormal.

•  Individualsremainasymptomaticbeyondinfancyandtoleratevariousstressorswithoutclinicalsymptomstypicallyassociatedwithmetabolicdecompensation.

•  Metaboliclabsmaybenormalwhentheindividualishealthy.•  Individualsmaypresentduringadolescenceoradulthoodwith

intermittentrhabdomyolysis,musclepainand/orexerciseintolerance,butitisunknownduringinfancyandchildhoodifthelatemyopathicpresentationwilloccurlaterinlife.

Page 11: Nutrition Guideline Development Process

Nutrition Management Guidelines ModerateVLCAD

•  Infantshavemildlytomoderatelyelevatedconcentrationsoflongchainacylcarnitinesonnewbornscreening.

•  Diagnostictesting,includinganabnormalplasmaacylcarnitineprofile,shouldconfirmthediagnosis.

•  Individualsareasymptomaticatdiagnosis,butmayexperience,orareconsideredathighriskfor,episodesofhypoketotichypoglycemiaorrhabdomyolysiswithstressorssuchasillness,fastingorexercise.

•  Metaboliclabsremainabnormalevenwhenpatientishealthy.However,cardiomyopathyorothercardiacpresentationisconsideredunlikely.

Page 12: Nutrition Guideline Development Process

Nutrition Management Guidelines SevereVLCAD

•  Infantshavesignificantlyelevatedconcentrationsoflongchainacylcarnitinesonnewbornscreening.

•  Diagnostictesting,includinganabnormalplasmaacylcarnitineprofile,shouldconfirmthediagnosis.

•  Individualsmaybesymptomaticatdiagnosisorwithinthefirstmonthsoflife.

•  Theclinicalpicturemayincludehypertrophicordilatedcardiomyopathy,pericardialeffusionandarrythmias,aswellashypotonia,hepatomegaly,intermittenthypoglycemiaandrhabodomyolysis.

Page 13: Nutrition Guideline Development Process

Nutrition Management Guidelines

Severe Moderate Mild

Cardio-myopathy

Q3Supplements

Asymptomatic(Q1)

Illness/Symptomatic(Q2)

Exercise

Q.5

VLCADClassifications

PregnancyQ7

Q4Monitoring

Page 14: Nutrition Guideline Development Process

Nutrition Management Guidelines

VLCADResearchQuestions1.  ForhealthyindividualswithVLCAD,whatnutrientintakegoalsareassociatedwith

positiveoutcomes?2.  FortheindividualwithVLCADwhatnutritioninterventionsareassociatedwith

positiveoutcomesduringillness(includingcardiomyopathyorrhabdomyolsis),surgeryorotherstress?

3.  ForindividualswithVLCAD,dootherspecificnutrientsupplementationorothertreatmentmodalities(i.e.L-carnitine,triheptanoin,bezafibrates)improveoutcomes?

4.  ForindividualswithVLCAD,monitoringofwhichparametersisassociatedwithpositiveoutcomes?ForindividualswithVLCAD,monitoringofwhichparametersisassociatedwithpositiveoutcomes?

5.  FortheindividualwithVLCADwhatnutritioninterventionsareassociatedwithpositiveoutcomesduringexercise?

6.  ForthewomanwithVLCAD,whatnutritioninterventionsareassociatedwithpositiveoutcomesduringmenstruation,pregnancy,deliveryandthepost-partumperiod?

Page 15: Nutrition Guideline Development Process

Nutrition Management Guidelines Ex:Question1-Topics

•  ForhealthyindividualswithVLCAD,whatnutrientintakegoalsareassociatedwithpositiveoutcomes.–  Dietcompositionbasedonseverity

•  Fatcomposition•  Macronutrients

–  Breastfeeding–  Essentialfattyacids–  Cornstarch/nighttimesnack/nightdripfeedings